EPSILOGEN LTD
Get an alert when EPSILOGEN LTD files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Cash
£9.6m
+24.1% highest in 3 filed years
Net assets
£23m
+126.9% highest in 3 filed years
Employees
22
+4.8% highest in 3 filed years
Profit before tax
-£12m
+8.3% highest in 3 filed years
Net assets
3-year trend · vs Industrials median
Accounts
3-year trend · Δ = latest vs prior filed period · latest reflected 2025-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 | 2025-12-31 | Δ vs prior |
|---|---|---|---|---|---|
| Turnover | — | — | — | — | |
| Operating profit | -£12,365,682 | -£12,587,150 | -£11,602,499 | +7.8% | |
| Profit before tax | -£12,135,966 | -£12,575,668 | -£11,531,495 | +8.3% | |
| Net profit | -£10,090,031 | -£10,103,663 | -£9,616,729 | +4.8% | |
| Cash | £8,881,189 | £7,765,228 | £9,639,338 | +24.1% | |
| Total assets less current liabilities | — | £12,144,131 | £25,351,840 | +108.8% | |
| Net assets | £6,915,316 | £10,231,394 | £23,214,538 | +126.9% | |
| Equity | £6,915,316 | £10,231,394 | £23,214,538 | +126.9% | |
| Average employees | 15 | 21 | 22 | +4.8% | |
| Wages | £2,833,110 | £3,861,408 | £4,438,313 | +14.9% | |
| Directors' remuneration | £444,918 | £1,253,943 | £1,430,395 | +14.1% | |
| Highest paid director | £541,075 | £1,218,787 | £1,430,395 | +17.4% |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show —. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Return on capital employed | — | -103.6% | -45.8% | |
| Gearing (liabilities / total assets) | 54.7% | 30.6% | 21.2% | |
| Current ratio | 2.17x | 4.70x | 3.19x | |
| Interest cover | — | -76.31x | -94.00x |
Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Name history
Renamed 1 time since incorporation
- EPSILOGEN LTD 2020-04-17 → present
- IGEM THERAPEUTICS LIMITED 2016-07-26 → 2020-04-17
Audit & accounting basis
- Accounting basis
- IFRS
- Reporting scope
- Standalone (parent only)
- Auditor
- PricewaterhouseCoopers LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“As part of their going concern assessment, the directors have prepared budgets and cash flow forecasts to assess the cash requirement to continue in operational existence for a minimum period of 12 months from the date of the approval of these financial statements.”
Group structure
- EPSILOGEN LTD · parent
- TigaTx Inc. 100%
Significant events
- “On 19 March 2025 the Company acquired 100% of the issued share capital of TigaTx Inc., a US registered biotechnology company for a consideration satisfied entirely in equity of £10,749,999.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
6 active · 5 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| BJORDAL, Marianne, Dr | Director | 2022-02-24 | Jan 1977 | Norwegian |
| FINAN, Peter Michael, Dr | Director | 2017-03-31 | Jul 1967 | British |
| GULATI, Sonia | Director | 2025-03-13 | Sep 1977 | American |
| SAFARIAN, Alek | Director | 2018-11-21 | Oct 1964 | Australian |
| UTENG, Marianne, Dr | Director | 2022-02-24 | Dec 1977 | Norwegian |
| WILSON, Timothy Craig, Dr | Director | 2017-06-01 | Mar 1964 | British |
Show 5 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| CHISWELL, David John | Director | 2019-04-24 | 2024-04-24 |
| COX, Vivienne Frances, Dr | Director | 2017-03-31 | 2022-02-24 |
| JOHNSON, Emma | Director | 2023-02-01 | 2025-12-10 |
| KARAGIANNIS, Sophia, Dr | Director | 2016-07-26 | 2017-03-31 |
| SIRINAKIS, Kyparissia Katie | Director | 2017-03-31 | 2018-11-21 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Epidarex Capital Iii Uk, Lp | Corporate entity | Shares 25–50%, Voting 25–50% | 2020-03-31 | Ceased 2023-12-15 |
| Mr Alek Safarian | Individual | Shares 25–50%, Voting 25–50% | 2020-03-31 | Ceased 2022-02-24 |
| Alsa Uk Holdings Ltd | Corporate entity | Shares 25–50%, Voting 25–50% | 2020-03-31 | Ceased 2020-09-28 |
| Epidarex Capital Ii, Lp | Corporate entity | Shares 25–50%, Voting 25–50% | 2017-06-26 | Ceased 2023-12-15 |
| Epidarex Capital Partners Limited | Corporate entity | Shares 25–50%, Voting 25–50% | 2017-03-31 | Ceased 2017-06-26 |
| Dr Sophia Karagiannis | Individual | Shares 25–50%, Voting 25–50% | 2016-07-26 | Ceased 2017-03-31 |
| Dr James Frederick Spicer | Individual | Shares 25–50%, Voting 25–50% | 2016-07-26 | Ceased 2017-03-31 |
| Vivienne Frances Cox | Individual | Shares 25–50%, Voting 25–50% | 2016-07-26 | Ceased 2017-03-31 |
Filing timeline
Last 20 of 107 total filings
Material constitutional events — rename, articles re-file, resolution
- 2025-04-02 MA Memorandum articles
- 2025-04-02 RESOLUTIONS Resolution
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-09-30 | AA | accounts | Accounts with accounts type full | |
| 2026-07-14 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2026-07-13 | CH01 | officers | Change person director company with change date | |
| 2026-05-13 | CH01 | officers | Change person director company with change date | |
| 2025-12-10 | TM01 | officers | Termination director company with name termination date | |
| 2025-10-04 | AA | accounts | Accounts with accounts type full | |
| 2025-08-18 | SH01 | capital | Capital allotment shares | |
| 2025-07-25 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2025-06-20 | SH01 | capital | Capital allotment shares | |
| 2025-06-17 | CH01 | officers | Change person director company with change date | |
| 2025-04-09 | SH01 | capital | Capital allotment shares | |
| 2025-04-04 | SH01 | capital | Capital allotment shares | |
| 2025-04-03 | SH01 | capital | Capital allotment shares | |
| 2025-04-02 | MA | incorporation | Memorandum articles | |
| 2025-04-02 | RESOLUTIONS | resolution | Resolution | |
| 2025-03-27 | AP01 | officers | Appoint person director company with name date | |
| 2024-09-10 | SH01 | capital | Capital allotment shares | |
| 2024-09-06 | SH01 | capital | Capital allotment shares | |
| 2024-09-05 | SH01 | capital | Capital allotment shares | |
| 2024-09-04 | SH01 | capital | Capital allotment shares |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 6
- Capital events
- 5
- Officers appointed
- 0
- Officers resigned
- 1
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.